Sanara MedTech Inc.

NASDAQ:SMTI

Medical - Instruments & Supplies

Healthcare
$32.73 +3.44%

+$0.73 today

Market cap
$300.55M
Beta
1.19
P/E (TTM)
-5.7
EPS (TTM)
-$3.86
52W Low $16.05High $35.95

Volume 0.07M

Average 0.06M

SMTI Cash & Equivalents

Cash on hand and highly liquid investments that can be converted to cash almost immediately.

Sanara MedTech Inc.NASDAQ: SMTI

Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026

Cash & equivalents falls 34.3% from a year ago

Cash & equivalents stood at $13.59M at the end of Q1 FY2026, down 34.3% from a year earlier and down 18.0% from the prior quarter. Over 3 fiscal years it compounded at +22.8% a year.

Context

  • Cash & equivalents amounted to 19.6% of total assets at the end of Q1 FY2026, down 1.8 pp from a year earlier.
  • Cash & equivalents increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -34.3% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$13.59M-18.0% QoQ
Last fiscal yearDec 2025
$16.58M+4.4% YoY
Year agoMar 2025
$20.69M-34.3% since
Cash & Equivalents past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-34.3%——
1 year+4.4%——
3-year CAGR+22.8%——
5-year CAGR——
10-year CAGR——

Cash & Equivalents history

USD · from the balance sheet

Latest · FY2025
16.58M USD
Year-over-year change
+4.4%
4-year CAGR
-2.9%

Cash & Equivalents vs competitors

How SMTI compares with its peers on the latest reported figures

  • Peers report in different currencies, so cash & equivalents is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -34.3% is the lowest of 10, against a peer median of +5.2%.
  • Cash & equivalents amounts to 19.6% of total assets for SMTI, versus a peer median of 22.8%.
SMTI Competitors
Cash & Equivalents for SMTI and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
NEONeoGenomics, Inc.Jun 2026$145.54M USD-5.9%-15.4%10.8%
SGHTSight Sciences, Inc.Mar 2026$84.96M USD-21.9%-20.8%77.4%
TRDAEntrada Therapeutics, Inc.Mar 2026$76.44M USD+12.7%+26.0%22.8%
HITIHigh Tide Inc.Apr 2026CA$36.51M CAD+5.2%+24.0%10.5%
TBRGTruBridge, Inc.Mar 2026$35.42M USD+249.9%+52.9%8.7%
LFMDLifeMD, Inc.Mar 2026$34.48M USD+0.2%+110.2%49.2%
XGNExagen Inc.Mar 2026$21.51M USD+92.2%-19.8%41.4%
STXSStereotaxis, Inc.Mar 2026$14.62M USD+37.9%+16.1%27.1%
SMTISanara MedTech Inc.Mar 2026$13.59M USD-34.3%+22.8%19.6%
VMDViemed Healthcare, Inc.Mar 2026$9.76M USD-3.9%-7.2%4.9%
Peer median (excluding SMTI) —+5.2%+16.1%22.8%

Competitors are the stored peer set for SMTI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents18.65M8.96M5.15M15.88M16.58M
Short-term Investments00000
Net Receivables2.99M7M8.53M13.55M12M
Inventory2.05M3.55M4.72M2.75M3.95M
Other Current Assets01.1M608.41K1.12M1.02M
Total Current Assets24.61M20.62M19.01M33.31M33.54M
Property, Plant & Equipment (Net)2.04M2.22M3.25M1.88M2.53M
Goodwill03.6M3.6M3.6M3.6M
Intangible Assets4.73M31.51M44.93M41.01M18.64M
Long-term Investments5.02M3.08M3.08M8.3M14.63M
Tax Assets00000
Other Non-current Assets(1)0000
Total Non-current Assets11.79M40.42M54.87M54.79M39.4M
Total Assets36.4M61.04M73.87M88.09M72.94M
Account Payables593.97K1.43M2M1.5M2.34M
Short-term Debt00580.36K0353.23K
Tax Payables00000
Deferred Revenue002.05M01.23M
Other Current Liabilities01.16M(947.68K)0235K
Total Current Liabilities6.02M12.81M13.77M15.29M18.63M
Long-term Debt009.11M30.69M45.97M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities06M4.66M1.96M548.13K
Total Non-current Liabilities222.15K6.51M15.52M33.89M48.39M
Total Liabilities6.24M19.32M29.28M49.18M67.01M
Common Stock7.68K8.3K8.54K8.75K8.95K
Retained Earnings(15.24M)(23.39M)(28.04M)(37.78M)(75.3M)
Accumulated OCI00000
Other Stockholders Equity0000(8.67K)
Minority Interest(488.4K)(107.56K)(244.26K)(491.61K)(8.67K)
Total Equity30.15M41.72M44.59M38.91M5.93M
Total Debt425.44K819.22K11.79M32.29M48.19M
Net Debt(18.23M)(8.14M)6.64M16.41M31.61M

Sanara MedTech Inc.

NASDAQ:SMTI

Intrinsic Alpha fair value

Locked

Current Price

$32.73

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.